Mrna-4157/v940, an investigational personalized mrna cancer vaccine, in combination with keytruda(r) (pembrolizumab), receives prime scheme designation from the european medicines agency for adjuvant treatment of patients with high-risk stage iii/iv melanoma following complete resection
Designation based on positive data from phase 2b keynote-942/mrna-4157-p201 trial and unmet need for additional therapeutic options for certain types of melanoma cambridge, ma and rahway, nj / accesswire / april 6, 2023 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, and merck (nyse:mrk), known as msd outside of the united states and canada, today announced that mrna-4157/v940, an investigational personalized mrna cancer vaccine, in combination with keytruda, merck's anti-pd-1 therapy, has been granted priority medicines (prime) scheme designation by the european medicines agency (ema) for the adjuvant treatment of patients with high-risk stage iii/iv melanoma following complete resection. the ema granted prime scheme designation based on positive data from the phase 2b keynote-942/mrna-4157-p201 trial.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission